CDKN1A and breast carcinoma: An association between the risk of acute skin toxicity and TP53 72Pro carriers in those with the CDKN1A 31Ser genotype in a subset of normal weight patients treated with radiotherapy for breast cancer has been shown (Tan et al, 2006).